Financhill
Buy
80

PPL Quote, Financials, Valuation and Earnings

Last price:
$36.35
Seasonality move :
2.05%
Day range:
$36.07 - $36.41
52-week range:
$27.24 - $36.70
Dividend yield:
2.89%
P/E ratio:
26.76x
P/S ratio:
3.09x
P/B ratio:
1.87x
Volume:
3.7M
Avg. volume:
6.3M
1-year change:
28.59%
Market cap:
$26.7B
Revenue:
$8.5B
EPS (TTM):
$1.35
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $5.5B $5.8B $7.9B $8.3B $8.5B
Revenue Growth (YoY) -2.29% 5.65% 36.64% 5.19% 1.81%
 
Cost of Revenues $2.7B $3.1B $5B $5B $5.1B
Gross Profit $2.8B $2.7B $2.9B $3.3B $3.4B
Gross Profit Margin 50.93% 46.91% 36.54% 39.41% 40.1%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$7M $3M $50M -$72M $81M
Operating Expenses $1.2B $1.3B $1.5B $1.6B $1.7B
Operating Income $1.6B $1.4B $1.4B $1.6B $1.7B
 
Net Interest Expenses $625M $906M $509M $634M $705M
EBT. Incl. Unusual Items $954M $521M $915M $924M $1.1B
Earnings of Discontinued Ops. $829M -$1.5B $42M -- --
Income Tax Expense $314M $503M $201M $184M $228M
Net Income to Company $640M $18M $714M $740M $888M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.5B -$1.5B $756M $740M $888M
 
Basic EPS (Cont. Ops) $1.91 -$1.93 $1.03 $1.00 $1.20
Diluted EPS (Cont. Ops) $1.91 -$1.93 $1.02 $1.00 $1.20
Weighted Average Basic Share $768.6M $762.9M $736M $737M $737.8M
Weighted Average Diluted Share $769.4M $764.8M $736.9M $738.2M $739.9M
 
EBITDA $2.7B $2.6B $2.7B $2.9B $3.2B
EBIT $1.6B $1.4B $1.4B $1.6B $1.9B
 
Revenue (Reported) $5.5B $5.8B $7.9B $8.3B $8.5B
Operating Income (Reported) $1.6B $1.4B $1.4B $1.6B $1.7B
Operating Income (Adjusted) $1.6B $1.4B $1.4B $1.6B $1.9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.5B $1.8B $2.4B $2.3B $2.5B
Revenue Growth (YoY) 4.03% 18.96% 35.52% -4.6% 8.68%
 
Cost of Revenues $764M $997M $1.5B $1.4B $1.4B
Gross Profit $734M $785M $921M $949M $1.1B
Gross Profit Margin 49% 44.05% 38.14% 41.19% 44.45%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- $1M $21M $13M $23M
Operating Expenses $319M $331M $423M $404M $435M
Operating Income $415M $454M $498M $545M $678M
 
Net Interest Expenses $153M $108M $155M $170M $185M
EBT. Incl. Unusual Items $262M $347M $364M $388M $516M
Earnings of Discontinued Ops. -$2B -- -- -- --
Income Tax Expense $59M $74M $79M $81M $102M
Net Income to Company $203M $273M $285M $307M $414M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.8B $273M $285M $307M $414M
 
Basic EPS (Cont. Ops) -$2.39 $0.37 $0.39 $0.42 $0.56
Diluted EPS (Cont. Ops) -$2.39 $0.37 $0.39 $0.42 $0.56
Weighted Average Basic Share $769.2M $735.5M $736.8M $737.5M $738.7M
Weighted Average Diluted Share $770.7M $736.2M $737.7M $738.8M $741.4M
 
EBITDA $693M $733M $858M $907M $1B
EBIT $415M $455M $528M $567M $706M
 
Revenue (Reported) $1.5B $1.8B $2.4B $2.3B $2.5B
Operating Income (Reported) $415M $454M $498M $545M $678M
Operating Income (Adjusted) $415M $455M $528M $567M $706M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $5.5B $6.1B $8.5B $8.2B $8.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.7B $3.3B $5.5B $4.9B $5.1B
Gross Profit $2.8B $2.8B $3B $3.3B $3.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$2M $4M $70M -$79M $91M
Operating Expenses $1.2B $1.3B $1.6B $1.6B $1.7B
Operating Income $1.6B $1.5B $1.4B $1.7B $1.9B
 
Net Interest Expenses $624M $861M $556M $650M $720M
EBT. Incl. Unusual Items $951M $606M $932M $948M $1.2B
Earnings of Discontinued Ops. -$1.6B $545M -- -- --
Income Tax Expense $312M $518M $206M $186M $249M
Net Income to Company $639M $88M $726M $762M $995M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$925M $633M $768M $762M $995M
 
Basic EPS (Cont. Ops) -$1.19 $0.85 $1.05 $1.03 $1.35
Diluted EPS (Cont. Ops) -$1.19 $0.85 $1.05 $1.03 $1.35
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.7B $2.6B $2.8B $3B $3.4B
EBIT $1.6B $1.5B $1.5B $1.6B $2B
 
Revenue (Reported) $5.5B $6.1B $8.5B $8.2B $8.7B
Operating Income (Reported) $1.6B $1.5B $1.4B $1.7B $1.9B
Operating Income (Adjusted) $1.6B $1.5B $1.5B $1.6B $2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.5B $1.8B $2.4B $2.3B $2.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $764M $997M $1.5B $1.4B $1.4B
Gross Profit $734M $785M $921M $949M $1.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- $1M $21M $13M $23M
Operating Expenses $319M $331M $423M $404M $435M
Operating Income $415M $454M $498M $545M $678M
 
Net Interest Expenses $153M $108M $155M $170M $185M
EBT. Incl. Unusual Items $262M $347M $364M $388M $516M
Earnings of Discontinued Ops. -$2B -- -- -- --
Income Tax Expense $59M $74M $79M $81M $102M
Net Income to Company $203M $273M $285M $307M $414M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.8B $273M $285M $307M $414M
 
Basic EPS (Cont. Ops) -$2.39 $0.37 $0.39 $0.42 $0.56
Diluted EPS (Cont. Ops) -$2.39 $0.37 $0.39 $0.42 $0.56
Weighted Average Basic Share $769.2M $735.5M $736.8M $737.5M $738.7M
Weighted Average Diluted Share $770.7M $736.2M $737.7M $738.8M $741.4M
 
EBITDA $693M $733M $858M $907M $1B
EBIT $415M $455M $528M $567M $706M
 
Revenue (Reported) $1.5B $1.8B $2.4B $2.3B $2.5B
Operating Income (Reported) $415M $454M $498M $545M $678M
Operating Income (Adjusted) $415M $455M $528M $567M $706M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $442M $3.6B $356M $331M $306M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $603M $583M $896M $950M $961M
Inventory $302M $322M $443M $505M $511M
Prepaid Expenses $53M $60M $92M $103M $136M
Other Current Assets $130M $106M $335M $344M $405M
Total Current Assets $20.9B $5B $2.8B $2.9B $2.9B
 
Property Plant And Equipment $24.5B $25.5B $30.2B $31.4B $33.1B
Long-Term Investments -- -- -- -- --
Goodwill $716M $716M $2.2B $2.2B $2.2B
Other Intangibles $351M $343M $313M $306M $314M
Other Long-Term Assets $387M $451M $395M $459M $419M
Total Assets $48.1B $33.2B $37.8B $39.2B $41.1B
 
Accounts Payable $745M $679M $1.2B $1.1B $1.2B
Accrued Expenses $113M $81M $97M $124M $157M
Current Portion Of Long-Term Debt -- $474M $354M $1M $551M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $11.6B $619M $862M $816M $837M
Total Current Liabilities $15.1B $2.3B $3.8B $3.3B $3.3B
 
Long-Term Debt $13.6B $10.7B $12.9B $14.6B $16B
Capital Leases -- -- -- -- --
Total Liabilities $34.7B $19.5B $23.9B $25.3B $27B
 
Common Stock $8M $8M $8M $8M $8M
Other Common Equity Adj -$4.2B -$157M -$124M -$163M -$184M
Common Equity $13.4B $13.7B $13.9B $13.9B $14.1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $3M -- --
Total Equity $13.4B $13.7B $13.9B $13.9B $14.1B
 
Total Liabilities and Equity $48.1B $33.2B $37.8B $39.2B $41.1B
Cash and Short Terms $442M $3.6B $356M $331M $306M
Total Debt $15.9B $11.2B $14.2B $15.6B $16.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $421M $4.2B $460M $276M $312M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $634M $625M $1B $999M $1.2B
Inventory $260M $280M $434M $477M $476M
Prepaid Expenses $132M $135M $175M $212M $223M
Other Current Assets $153M $101M $372M $431M $407M
Total Current Assets $20.3B $5.7B $3B $3B $3.1B
 
Property Plant And Equipment $24.7B $25.6B $30.5B $31.7B $33.6B
Long-Term Investments -- -- -- -- --
Goodwill $716M $716M $2.2B $2.2B $2.2B
Other Intangibles $348M $340M $310M $304M $312M
Other Long-Term Assets $393M $474M $429M $437M $463M
Total Assets $47.8B $34.1B $38.3B $39.6B $41.8B
 
Accounts Payable $660M $686M $1.1B $903M $1.1B
Accrued Expenses $182M $138M $164M $214M $224M
Current Portion Of Long-Term Debt -- $1.5B $104M $1M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $11.9B $511M $824M $697M $819M
Total Current Liabilities $15.6B $3B $2.5B $2.4B $3.8B
 
Long-Term Debt $13.7B $10.7B $14.5B $15.8B $15.9B
Capital Leases -- -- -- -- --
Total Liabilities $36.2B $20.2B $24.3B $25.6B $27.5B
 
Common Stock $8M $8M $8M $8M $8M
Other Common Equity Adj -$3.9B -$152M -$123M -$161M -$184M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $3M -- --
Total Equity $11.6B $13.9B $14B $14.1B $14.3B
 
Total Liabilities and Equity $47.8B $34.1B $38.3B $39.6B $41.8B
Cash and Short Terms $421M $4.2B $460M $276M $312M
Total Debt $16.2B $12.1B $14.6B $16B $17.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $640M $18M $714M $740M $888M
Depreciation & Amoritzation $1.1B $1.1B $1.2B $1.3B $1.4B
Stock-Based Compensation -- $37M $37M $33M $46M
Change in Accounts Receivable -$67M -$19M -$373M -$42M $197M
Change in Inventories -$9M -$21M -$90M -$60M -$2M
Cash From Operations $2.7B $2.3B $1.7B $1.8B $2.3B
 
Capital Expenditures $2.3B $2B $2.2B $2.4B $2.8B
Cash Acquisitions -- $10.6B -$3.7B -- --
Cash From Investing -$3.3B $8B -$5.7B -$2.4B -$2.8B
 
Dividends Paid (Ex Special Dividend) -$1.3B -$1.3B -$787M -$704M -$747M
Special Dividend Paid
Long-Term Debt Issued $2.2B $650M $850M $3.3B $1.9B
Long-Term Debt Repaid -$1B -$5.7B -$264M -$1.9B --
Repurchase of Common Stock -- -$1B -- -- --
Other Financing Activities $171M -$7M -$6M -$51M -$23M
Cash From Financing $386M -$7.4B $709M $650M $435M
 
Beginning Cash (CF) $660M $443M $3.6B $357M $382M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$234M $3.1B -$3.2B $25M -$43M
Ending Cash (CF) $443M $3.6B $357M $382M $339M
 
Levered Free Cash Flow $476M $297M -$425M -$632M -$465M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $203M $273M $285M $307M $414M
Depreciation & Amoritzation $278M $278M $330M $340M $342M
Stock-Based Compensation $6M -- -- -- --
Change in Accounts Receivable $16M -$10M $15M -$18M -$169M
Change in Inventories $41M $42M $10M $33M $37M
Cash From Operations $663M $502M $430M $282M $513M
 
Capital Expenditures $471M $427M $499M $596M $793M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$735M -$427M -$1B -$591M -$783M
 
Dividends Paid (Ex Special Dividend) -$320M -$306M -$171M -$177M -$190M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $752M -- $3.1B $1.1B --
Long-Term Debt Repaid -$373M -- -$1.8B -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$4M -$7M -$44M -$22M -$14M
Cash From Financing -$71M $603M $177M $248M $271M
 
Beginning Cash (CF) $443M $3.6B $357M $382M $339M
Foreign Exchange Rate Adjustment $8M -- -- -- --
Additions / Reductions -$29M $678M $104M -$61M $1M
Ending Cash (CF) $422M $4.3B $461M $321M $340M
 
Levered Free Cash Flow $192M $75M -$69M -$314M -$280M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $639M $88M $726M $762M $995M
Depreciation & Amoritzation $1.1B $1.1B $1.3B $1.3B $1.4B
Stock-Based Compensation -- $31M $37M -- --
Change in Accounts Receivable -$113M -$45M -$348M -$75M $46M
Change in Inventories -- -$20M -$122M -$37M $2M
Cash From Operations $2.7B $2.1B $1.7B $1.6B $2.6B
 
Capital Expenditures $2.1B $1.9B $2.2B $2.5B $3B
Cash Acquisitions -- $10.6B -$3.7B -- --
Cash From Investing -$3.2B $8.3B -$6.2B -$2B -$3B
 
Dividends Paid (Ex Special Dividend) -$1.3B -$1.3B -$652M -$710M -$760M
Special Dividend Paid
Long-Term Debt Issued $2.4B -$102M $4B $1.3B $746M
Long-Term Debt Repaid -$1.4B -$5.3B -$2B -$104M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $175M -$10M -$43M -$29M -$15M
Cash From Financing $75M -$6.7B $283M $721M $458M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$339M $3.8B -$3.8B -$140M $19M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $592M $180M -$569M -$877M -$431M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $203M $273M $285M $307M $414M
Depreciation & Amoritzation $278M $278M $330M $340M $342M
Stock-Based Compensation $6M -- -- -- --
Change in Accounts Receivable $16M -$10M $15M -$18M -$169M
Change in Inventories $41M $42M $10M $33M $37M
Cash From Operations $663M $502M $430M $282M $513M
 
Capital Expenditures $471M $427M $499M $596M $793M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$735M -$427M -$1B -$591M -$783M
 
Dividends Paid (Ex Special Dividend) -$320M -$306M -$171M -$177M -$190M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $752M -- $3.1B $1.1B --
Long-Term Debt Repaid -$373M -- -$1.8B -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$4M -$7M -$44M -$22M -$14M
Cash From Financing -$71M $603M $177M $248M $271M
 
Beginning Cash (CF) $443M $3.6B $357M $382M $339M
Foreign Exchange Rate Adjustment $8M -- -- -- --
Additions / Reductions -$29M $678M $104M -$61M $1M
Ending Cash (CF) $422M $4.3B $461M $321M $340M
 
Levered Free Cash Flow $192M $75M -$69M -$314M -$280M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 17.22% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is up 0.05% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 19.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock